Scilex Holding Company is making waves with their latest initiative to partner with national pharmacy chains to distribute GLOPERBA® across...
On February 28, 2024, Mizuho analyst Dan Dolev expressed optimism in Fidelity National Information Services (NYSE:FIS) by maintaining a Buy...
Deere has been a standout performer in the market over the past five years, with an impressive average annual return...
Canadian Natural Resources (NYSE:CNQ) is anticipated to reveal an earnings per share (EPS) of $1.60 for the upcoming quarterly earnings...
Evergy, a publicly traded company, is set to unveil its latest financial results on February 29, 2024. Industry experts are...
Vipshop's stock has seen a significant surge in value following the release of its impressive Q4 financial results on February...
Crinetics Pharmaceuticals has recently made headlines with their successful $350 million private placement, which saw the sale of 8,333,334 shares...
On February 28, 2024, Mizuho analyst Maheep Mandloi updated their rating on Array Technologies (NASDAQ: ARRY) to Neutral and decreased...
Ambarella's stock is on the rise in premarket trading after the company's Q4 FY24 results exceeded expectations. Despite a 38.1%...
Analyst Vikram Malhotra from Mizuho has decided to keep a Neutral rating on Mid-America Apartment Communities (NYSE: MAA) but has...
